FDA rejects petition to block Suboxone generics, refers case to FTC

02/26/2013 | Pharmalot.com

The FDA rejected a citizen petition filed by Reckitt Benckiser that was aimed at keeping generic-drug-makers from launching copies of Reckitt's Suboxone opioid dependence treatment. The FDA also referred the case to the Federal Trade Commission after generic-drug-makers said Reckitt participated in business practices that discouraged competition.

View Full Article in:

Pharmalot.com

Published in Brief: